However, our results demonstrate that IFN induction by ARV-infected CEF occurs by a caspase-independent mechanism.
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INTRODUCTION
Interferons (IFNs) comprise a family of multifunctional cytokines that were originally discovered by their strong antiviral activity (Isaacs and Lindenmann, 1957) , and which are now recognized as the first barrier that viruses have to overcome to establish a productive infection. Of the three IFN types, type I interferon- displays the highest antiviral activity and its expression is induced in many cell types by viral infection or following contact with double-stranded RNA (dsRNA) (reviewed in Samuel, 2001 ).
Successful host defense against viruses relies on early detection of intracellular virus particles followed by the rapid production of type I interferons. For this, cells contain a series of endosomal and cytosolic sensors, called pattern recognition receptors (PRRs), which recognize pathogen associated molecular patterns (PAMPs), such as viral nucleic acids or viral intermediate products. When contacting PAMPs, PRRs become activated and transmit intracellular signaling pathways, culminating in the activation of specific transcription factors that translocate to the nucleus to stimulate type I IFN promoters (reviewed in Diebold, 2010; Edwards et al., 2007; Jefferies and Fitzgerald, 2005; Koyama et al., 2008; Yoneyama and Fujita, 2010) . Newly-synthesized type I IFNs are secreted out of the cell to interact with the ubiquitously expressed IFNAR receptor complex present in neighboring cells. This interaction triggers the activation of a signal transduction pathway that leads to increased expression of the designated IFN-stimulated genes (ISGs), thus creating an antiviral state. Subsequent viral infection of IFN-primed cells induces the activation of ISG-encoded proteins; the antiviral activity of these proteins prevents further dissemination of the virus (reviewed in Doly et al., 1998; Haller et al., 2006; Sadler and Williams, 2008; Samuel, 2001 ; 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   4 Despite that IFN was initially discovered as a soluble chicken factor that directly interfered with influenza virus replication in chorioallontoic membranes of chicken embryos (Isaacs and Lindenmann, 1957) , our understanding of the host response to pathogens in poultry is very limited, since most efforts were dedicated at characterizing the antiviral response in mammals. However, interest in IFNs of birds has recently emerged from increasing problems with viral diseases in poultry and from the observation that chickens infected with highly pathogenic avian influenza virus strains pose a high threat to human health (Fouchier et al., 2013; Karpala et al., 2012; Poovorawan et al., 2013) . As in mammals, three types of chicken IFN (chIFN) have been identified in virus-infected chicken cells, and all three have been reported to display antiviral activity (reviewed in Goosens et al., 2013) . Type I chIFN, which comprises multiple chIFN- isoforms and a single chIFN-, has the strongest antiviral activity, although chIFN- is the dominant virus-induced IFN subtype produced by virus-infected avian cells (Schultz et al., 1995; Schwarz et al., 2004) , a situation opposite to the one found in mammalian-infected cells. This, and the observations that chIFN- exhibits stronger antiviral activity than chIFN- against several viruses and greater induction potency on several ISGs encoding antiviral proteins (Qu et al., 2013; Schwarz et al., 2004) , suggests that chIFN-is the main defense used by chicken cells to combat viral infections.
Previous studies from different laboratories, including ours, have revealed that the replication of avian reovirus (ARV) in cultured avian cells is much more resistant to the antiviral action of chIFN than vaccinia virus (VV), vesicular stomatitis virus (VSV) or Semliki Forest virus (Ellis et al., 1983; Gonzalez-Lopez et al., 2003; Martinez-Costas et al., 2000; Sekellick et al., 1994) . In this study we have examined the capacity of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 5 IFN is only expressed and secreted by ARV-infected cells and that IFN induction requires virus uncoating, but not the expression of the ARV genes. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 6 RESULTS:
IFN induction by virus-infected avian cells
In the first part of this study we sought to compare the capacity of ARV, VV and VSV to induce the production and secretion of IFN by infected avian cells. Our previous finding that VSV and VV are very sensitive to priming of CEF cells with IFN (Martinez-Costas et al., 2000) suggests that IFN should not be secreted by avian cells infected with these two viruses, otherwise the IFN present in the viral stocks used to infect the cells would block viral replication. In the case of VV, this suggestion is supported by the results of previous studies that revealed that chIFN activity was not detected upon infection of CEF cells with wild-type VV (Hornemann et al., 2003) . In contrast, it has been recently reported that infection of the CEF-derived avian cell line DF1 with VSV induces increasing expression of the mRNAs coding for chIFN- and chIFN- (Qu et al., 2013) , although the presence of IFN in the cultured medium of VSV-infected cells was not examined in this study.
To determine the capacity of the three viruses to induce chIFN expression, we first analyzed by Western blot the intracellular levels of the IFN-inducible protein PKR in virus-infected CEF cells. Since the possibility existed that IFN is produced and secreted by ARV-infected CEF, and consequently that the ARV stock used to infect the cells contains chIFN, the infection with ARV was carried out with a suspension of purified reovirions devoid of cellular proteins (Grande and Benavente, 2000) . VSV and VV viruses did not require purification since these viruses were grown on BHK-21 hamster cells and therefore their stocks should not contain chIFN. The results shown in Fig. 1A In the first approach, we examined the capacity of virus-free supernatants to induce PKR expression when incubated with monolayers of uninfected CEF. Viral particles were removed from the supernatants of infected cells by precipitation with perchloric acid at 4ºC, as previously reported (Sekellick and Marcus, 1986) , but similar results were obtained when the viral particles were inactivated by incubating the supernatants at 65ºC for 30 min (Liniger et al., 2012) . The results shown in Fig. 1B revealed that only the supernatant from ARV-infected cells, but not those from cells infected with VSV or VV, was able to induce the expression of PKR. In the second approach, we determined the capacity of the supernatants to activate the promoter of the chicken Mx gene contained within the reporter pGL3-P-chMx-luc plasmid (Liniger et al., 2012) .
The supernatants were incubated with plasmid-transfected DF1 cells, since control experiments revealed that the transfection of any plasmid into CEF cells, but not into DF1 cells, already induces PKR expression (not shown). The results shown in Fig. 1C revealed that only the supernatant from ARV-infected CEF was able to activate the Mx promoter. Taken together, these results demonstrate that infection of CEF with ARV, but not with VSV or VV, induces the production and secretion of chIFN. Our results further revealed that the secreted IFN is functional in both CEF and DF1 cells, since it is able to activate the expression of those IFN-responsive genes expressing PKR and Mx.
ARV-infected CEF secrete type-andtype-IFNs
To try to determine the type of chIFN (or ) produced by ARV-infected CEF cells, antibodies to chIFN- and/or - were added to the culture medium of the infected cells and the intracellular levels of PKR were monitored by Western blotting. The 8 results revealed that each of the two antibodies was capable of inhibiting PKR induction, although maximal inhibition was only reached when the two antibodies were simultaneously present in the culture medium ( Fig. 2A) . These results not only indicate that ARV-infected CEF cells secrete type- and type- chIFNs, but also suggest that PKR is indirectly induced in these cells by the IFN secreted to the cultured medium. To confirm this suggestion we analyzed the effect of brefeldin A (BFA) on PKR expression. BFA is a macrolide antibiotic that has been shown to inhibit vesicle transport to the cell surface, by causing the resorption of the Golgi complex into the endoplasmic reticulum (Miller et al., 1992; Nebenführ et al., 2002) . It has been shown that 0.25 g/ml of BFA only caused a slight reduction of both intracellular muNS levels and the production of infectious viral particles (Bodelon et al., 2002) 
IFN induction in ARV-infected cells requires viral uncoating, but not viral gene expression
Our next goal was to try to identify the stage of the ARV life cycle at which IFN expression is induced. First of all, we determined the relative production of chIFN- mRNA in ARV-infected CEF at different infection times. We analyzed the intrcellular levels of this mRNA because it is encoded by a single gene, whereas there are multiple 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 9 chIFN- genes. Real-time PCR analysis revealed that increased expression of the chIFN- mRNA was already observed at 3 hpi and its intracellular levels increased significantly at 6 hpi ( Fig. 3A) , indicating that strong induction of the chIFN- gene takes place at early infection times. To confirm this result we analyzed the intracellular PKR levels and the capacity of the supernatants to activate the Mx promoter at different infection times. Induction of PKR expression was already detected at 6 hpi and intracellular PKR levels increased with time until 12 hpi, and then declined probably because of the damage caused by the infection, as revealed by diminished actin levels ( Fig. 3B ). On the other hand, the capacity of the supernatant from infected cells to activate the Mx promoter was already detected at 3 hpi and steadily increased until 12 hpi ( Furthermore, the supernatants from ARV-infected CEF that had been incubated with either of the two inhibitors from the onset of the infection, but not when added 3 h later, were no longer able to activate the Mx promoter (Fig. 4B ). These results indicate that virus uncoating is required for IFN induction in ARV-infected cells. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 To determine whether ARV gene expression is necessary for IFN induction, we first evaluated the effect of ribavirin, a nucleoside analog that has been reported to block ARV transcription without affecting the expression of cellular genes (Labrada et al., 2002) . Our finding that the production of the ARV nonstructural muNS protein is blocked when ARV-infected cells are incubated in the presence of 100  ribavirin indicates that the nucleoside analog is effective in blocking ARV gene expression 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 (Alcamí and Koszinowski, 2000; Weber and Haller, 2007) .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 (Henderson and Joklik, 1978) and, if the same holds true for the treatment of avian reovirions, these transcripts could be the trigger for IFN induction.
Apoptosis activation and IFN induction are unrelated events
On the other hand, ribavirin has been shown to block transcription elongation, but not the initiation of RNA synthesis (Rankin et al., 1989) , so abortive reoviral transcripts generated in ribavirin-treated cells might act as IFN inducers. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 14 intraendosomal virus uncoating is necessary to trigger IFN expression and that the expression of IFN is induced at a post-attachment step. Our findings that IFN induction requires virus uncoating but not viral gene expression suggests that the viral PAMPs detected by the cellular PRRs should be ARV products generated or exposed upon intraendosomal uncoating, and not by intact viral particles. These products might be core proteins or viral nucleic acids, like the adenine-rich oligonucleotides or the genome segments present in ARV particles. Since reovirus cores must cross the endosomal Thus, as has been reported for mammalian reovirus protein sigma3 (Schmechel, et al., 1997) , localization of sigmaA in and around perinuclear viral factories would prevent 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 15 Alternatively, the sigmaA protein expressed in ARV-infected cells might partially inhibit PKR activation, leading to intracellular levels of phosphorylated eIF-2 that would block the translation of cellular mRNAs, but not of their viral counterparts. A pro-viral effect of PKR expression has similarly been reported for the replication of mammalian reoviruses (Smith et al., 2005) .   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 16
That lysosomotropic agents prevent IFN induction when added to ARV-infected cells at the onset of the infection, but not when added 3 h later, indicates both that

MATERIALS AND METHODS
Cells and viruses
Primary cultures of CEF cells were prepared from 9-to 10-day-old embryos from specific pathogenic free chickens, and grown as monolayers in medium 199 supplemented with 10% tryptose phosphate broth and 5% calf serum. Chicken Western Reserve strain) and Vesicular Stomatitis Virus (VSV; Indiana serotype) were grown on BHK-21 cell monolayers. Avian reovirus (ARV) strain S1133 was grown on semiconfluent monolayers of CEF cells, and purified by CsCl-gradient centrifugation as previously described (Grande and Benavente, 2000) , except that Freon was replaced by Vertrel-XF (Mendez et al., 2000) .
For ultraviolet inactivation, purified ARV virions kept on ice were exposed to a 254 nm UV light for 15 min, as described by Tyler et al. (1995) . UV-inactivated virus was devoid of infectious virus particles as determined by plaque assay.
Antibodies, plasmids and reagents
Anti-actin antibody (rabbit polyclonal, sc-1616R) was purchased from Santa Cruz Biotechnology and HRP-conjugated goat anti-rabbit IgG from Sigma. Rabbit polyclonal anti-muNS protein was raised in our laboratory (Tourís-Otero et al., 2004) . Rabbit polyclonal anti-chicken PKR antibody was generated by BioSynthesis, using as immunogen a KLH-conjugated synthetic peptide comprising amino acids 527-550 of chicken PKR. Rabbit antibodies against chicken IFNs  and  were a kind gift from Dr. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 17
The reporter plasmid that contains the luciferase gen under the control of the chicken Mx promoter (pGL3-P-chMx-Luc) was a gift from Dr. Nicolas Ruggli (Liniger et al., 2012) . Ammonium chloride, chloroquine, ribavirin and brefeldin A were purchased from Sigma, the pancaspase inhibitor Q-VD-OPh was from Calbiochem, lipofectamine from Invitrogen and the recombinant chicken IFN alpha from AbD-Serotec (#PAP004).
Western blotting
Cells were washed twice with PBS, lysed in Laemmli sample buffer (Laemmli, 1970) and boiled for 5 min. The resulting extracts were then subjected to SDS-PAGE electrophoresis, and the gel proteins transferred to PVDF membranes (Immobilon-P, Millipore) for 1 h at 100 V using a trans-blot electrophoretic transfer unit (Bio-Rad).
Membranes were blocked for 1 h with PBS containing 0.05% Tween-20 and 4% non-fat dry milk, and incubated for 2 h with the primary antibodies diluted in blocking solution.
After several washes, membranes were incubated for 45 min with HRP-conjugated goat anti-rabbit IgG and visualized by chemiluminescence (Immobilon Western Chemiluminescent HRP Substrate, Millipore).
Preparation of virus-free supernatants and Mx-promoter activation assays
The virus was removed from the supernatants by perchloric acid (PCA) precipitation (Sekellick and Marcus, 1986) . Briefly, foetal bovine serum in the culture medium was raised to 6% before adding 0.15 volumes of cold PCA. Samples were incubated for 24 h in a cold room and the precipitate removed by centrifugation at 2000 rpm 10 min. PCA in the supernatant was neutralized with KOH, and the pH adjusted to 6.8. The precipitate that forms after neutralization was removed by centrifugation, and the IFNcontaining supernatant was filter-sterilized through a 0.22-M Millex filter (Millipore) before further use. Alternatively, supernatants from monolayers of infected cells were   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 18 centrifugated at 4ºC for 5 min at 2000 rpm to remove cellular debris, and the resulting supernatants were incubated at 65ºC for 30 min to inactivate the virus (Liniger et al., 2012) .
To determine the activation of the chicken Mx promoter, monolayers of DF-1 cells were transfected with the pGL3-P-chMx-luc plasmid and incubated 24 h later with either 50 l of virus-free supernatants or 100 U/ml of IFN for 24 h. The cells were then harvested and lysed in CCLR buffer (Promega). The luciferase activity of the extracts was determined with a Luminoskan Ascent luminometer.
Quantitative real-time PCR of chIFN- mRNA levels in ARV-infected CEF cells.
CEF cell monolayers were infected with 2 PFU/cell of ARV S1133, and at 0, 3 and 6 hpi cell samples were collected and their RNA was extracted using Trizol (Life 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 19 a Tm of 63.4ºC). An initial denaturalization step of 3 min at 95ºC was followed by 40 cycles (10 s at 95ºC, 30 s at 63.4ºC and 10 s at 72ºC) using a C1000 Touch thermocycler with a CFX96 optical module (Bio-Rad). An end-point single fluorescence was measured after each extension step. After the amplification we carried out an analysis of the dissociation curve from 65 to 95ºC by raising the temperature 0.5ºC every 5 s, to verify the specificity of the obtained products. The results were analysed and processed with the CFX Manager software (Bio-Rad). The relative amount of the mRNA was normalized to the internal β-actin control, and chicken β-actin gene expression was detected using previously described primers (Li et al., 2007) .
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